The combination of revenue beat, EPS beat, and raised guidance suggests strong underlying momentum; monitor upcoming quarters for sustainability of organic volume growth and margin expansion.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 21 $205.04entry
- T+1 · 7mo ago −0.51%α −1.53% · $204.00
- T+5 · 7mo ago −4.87%α −5.96% · $195.05
- T+20 · 6mo ago −7.41%α −12.33% · $189.84
- T+60 · 4mo ago +2.13%α −4.77% · $209.41
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Quest Diagnostics reported strong Q1 2026 results with revenue of $2.90 billion (up 9.2% YoY) and reported EPS of $2.24 (up 15.5% YoY), beating consensus. The company raised full-year 2026 EPS guidance, signaling confidence in sustained growth from organic volume expansion and operational execution.
Key Financial Metrics
Key Facts
- Q1 2026 revenue was $2.90 billion, up 9.2% YoY with 9.0% organic growth
- Reported diluted EPS was $2.24, up 15.5% YoY; adjusted EPS was $2.50, up 13.1% YoY
- Company raised full-year 2026 adjusted EPS guidance to $10.63–$10.83 (from $10.50–$10.70)
Financial Impact
Revenue increased $250 million and EPS increased $0.30 YoY, with guidance raised above prior expectations
Risk Factors
- Guidance raise depends on continued execution of Project Nova and Co-Lab integrations
- Exposure to reimbursement policy changes in clinical laboratory testing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001022079-26-000040 |
| Document: dgx-20260421.htm | 0001022079-26-000040 |
| Document: 0001022079-26-000040-index-headers.html | 0001022079-26-000040 |
| Document: 0001022079-26-000040-index.html | 0001022079-26-000040 |
| Document: 0001022079-26-000040.txt | 0001022079-26-000040 |
| 8-K Data (Synthetic) | 0001022079-26-000040 |
Track record
23 reports on DGX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20263d ago Insider Cluster Neutral 2/10 Entry $259.65 Now $261.92 +0.87% settles Feb 11
- Nov 10, 20265d ago Press Release Neutral 2/10 Entry $258.69 Now $261.92 +1.25% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $261.92 +1.35% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $261.92 +0.87% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $261.92 +0.87% settles Feb 5
- Nov 5, 202610d ago 3 Neutral 2/10 Entry $255.63 Now $261.92 +2.46% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $261.92 +6.01% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $261.92 +6.01% settles Feb 1
- Oct 27, 202619d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $261.92 +6.64% settles Jan 26
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $242.95 Now $261.92 +7.81% settles Jan 22
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers